Sharon Will The EUNI HORSEWOMEN and the 6 HORSEMEN LOL
RAFI KHAN, EDWARD WILLIAMSSON, MARK BERGMAN, REGIS POSSINO, ROBERT PRATT, AND HARRIS FREEDMAN HAVE ALL BEEN INVOLVED IN EUNI'S STOCK.
MORE HORSEWOMEN AND HORSEMEN TO BE ADDED TO THE LIST AS TIME PERMITS
Yet another fraudulent promoter tied to EUNI, Rafi Khan, Sharon Will and Harris Freedman. LOL
Both Harris and Will show up as warrant holders of euni
July 29, 1999Yet another fraudulent stock promoter tied to Hemispherx.Rafi M. Khan, a stockbroker who has been charged with stock manipulation by the Securities and Exchange Commission ("SEC"), has been tied to Hemispherx Biopharma, Inc. (AMEX: HEB) (Price: $7.125). In a July 30, 1998 complaint, the SEC charged Mr. Khan with manipulating share prices in two companies. Mr. Khan allegedly conducted his illegal stock promotion while operating the one-person Southern California office of Shamrock Partners, Ltd. ("Shamrock"). According to an NASD Public Disclosure statement, Mr. Khan was employed by Shamrock from October 24, 1994 until December 30, 1996.In an SEC Form 424B3 dated September 30, 1996, Hemispherx disclosed that it had entered into a consulting agreement with Shamrock in August 1996 wherein Hemispherx granted Shamrock an option to purchase 600,000 shares of HEB stock during the five-year period beginning August 15, 1996, at an exercise price of $2.50 per share. In an SEC filing dated February 25, 1998, Hemispherx registered 600,000 shares for Shamrock. These 600,000 shares represented shares of common stock underlying warrants exercisable through August 15, 2001 at $2.50 per share. Hemispherx paid for the cost of registration, which would allow Shamrock to sell its privately obtained, cheap, insider shares to the public without further notice or disclosure.Mr. Khan joins a group of fraudulent stock promoters associated with Hemispherx that includes Stratton Oakmont, Inc., which was in December 1996 expelled from the NASD; Stratton’s former chairman, Jordan Belfort, who in September 1998 was indicted and charged with conspiracy, fraud, money laundering and obstruction; and Monroe Parker Securities, Inc., which was in October 1998 named as a defendant in a New York State Attorney General ("NYSAG") stock-manipulation indictment.There are numerous other promoters tied to Hemispherx, including Harris Freedman and Sharon Will, who have been vice presidents of Hemispherx since 1994, and a former Hemispherx board member, Stephen J. Drescher. These three have all been associated with three of the companies, including Hemispherx, named in a press release announcing the NYSAG indictment. Among other HEB stock promoters are David C. Drescher, who is related to Stephen Drescher and is the president of Millenium International Communications, Ltd., and Value Management & Research AG ("VMR"), which has released a series of Hemispherx research reports, including one dated April 26, 1999 that made false Ampligen HIV efficacy claims. On April 13, 1999, Hemispherx filed a registration statement with the SEC to allow VMR to sell 750,000 HEB shares plus 250,000 shares underlying warrants.Further details of the fraudulent VMR report and the involvement of HEB officers in other manipulated stocks can be found here. Ever since its 1995 IPO, Hemispherx has regularly granted options and registered new shares for individuals and entities proved to be stock promoters. This in turn has created the incentive for Hemispherx’s continual, fraudulent stock promotion.Short selling involves a risk not associated with the purchase of stock including, but not only limited to, unlimited loss and stock borrowing risks. Additional information is available upon request
--------------------------------
EUNIVERSE INC
Form: 10-Q Filing Date: 11/14/2001
freeedgar.com, Inc. Common Stock Purchase Warrant issued to Saggi Capital Corp., datedSeptember 25, 2001.*
------------------------------------------
"CONTACT: Sharon Will of Saggi Capital Corporation, 212-572-0762,December 21, 1999 15:45CRYO-CELL Releases 4th Quarter 1999 Interim Revenue FiguresCLEARWATER, Fla., Dec. 21 /PRNewswire/ -- Daniel Richard, Chief Executive Officer of CRYO-CELL International, Inc. (Nasdaq: CCEL), announced the company's fourth quarter interim revenue figures for the period ended November 30, 1999. Highlights of the quarterly sales results include the following: -- Q4, 1999 sales of $813,654 represent a 516% increase over Q4, 1998 sales of $132,009 -- YTD sales (12 months) of $1,675,694 represent a 406% increase over 1998 sales of $331,134 for the same period -- Q4 sales represent a 146% increase over Q3 sales of $330,824 The fourth-quarter revenues include the previously announced partial State Revenue Sharing Agreement. In addition, the figures do not include a $100,000 irrevocable deposit that the Company received with a signed Letter of Intent for the marketing rights in Continental Europe. The balance of $1,300,000 will be recorded as a receivable when the final agreement is signed in the first quarter of fiscal year 2000. Jill Taymans, Chief Financial Officer, stated, "The Company currently has $1,500,000 on hand with no debt. Considering the revenues that are currently being generated and the receipt of our accounts receivable, the Company will have sufficient operating capital for more than 24 months." Gerald F. Maass, Executive Vice President and General Manager, commented, "The sales for the current month are reaching record levels. In addition, there are a number of marketing initiatives commencing in the first quarter of the Year 2000 which the Company believes will significantly increase its revenues." The Company will complete its 10-KSB filing on a timely basis in the first quarter of 2000. CRYO-CELL has pioneered America's most affordable U-Cord(TM) preservation program. Expectant parents can call 800-STOR-CELL (800-786-7235), or visit the web site: cryo-cell.com . CRYO-CELL is a publicly traded company. Its common stock trades on the Nasdaq Stock Market (R) under the symbol CCEL. Forward-Looking Statement Statements wherein the terms "believes," "intends," or "expects" as used are intended to reflect "forward-looking statements" of the Company. The information contained herein is subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements or paragraphs. Readers should carefully review the risk factors described in other documents the Company files from time to time with the Securities and Exchange Commission, including the most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K filed by the Company. SOURCE CRYO-CELL International, Inc. /CONTACT: Sharon Will of Saggi Capital Corporation, 212-572-0762, or fax,
212-572-0764, for CRYO-CELL International, Inc./ /Web site: cryo-cell.com / (CCEL
To:A@P Trader who wrote (472)
From: TheTruthseeker Thursday, Sep 23, 1999 1:34 PM
View Replies (1) | Respond to of 536 My My My where is Sharon Will and Harris Freedman today? Hemisphere BioPharma Inc and Big City Bagels Inc. news must make them get goose bumps all over their bodies!!Stratton Oakmont Execs Plead Guilty to Expanded Fraud ChargesNew York, Sept. 23 (Bloomberg) -- The former chairman and president of Stratton Oakmont Inc., a defunct brokerage firm, have pleaded guilty to an expanded series of stock-fraud charges, federal prosecutors said. Former Chairman Jordan Belfort, 37, and Daniel Porush, 42, who was president of the firm, were charged last September by the U.S. Attorney in Brooklyn with 27 counts including securities fraud, money laundering and obstruction of justice, in a scheme that lasted from 1990 to 1997. Belfort pleaded guilty in May and Porush, in December, to two counts each of conspiracy to commit stock fraud and money laundering. The pleadings unsealed today indicate that the fraud at Stratton was greater than previously disclosed. Belfort and Porush each pleaded guilty to eight new criminal counts, including manipulating the prices of at least 34 initial public offerings Stratton underwrote and money laundering now believed to total at least $80 million. Porush also pleaded guilty to charges of conspiring to trade on inside information involving a proposed merger between ITT Corp. and Caesar's World while at Stratton, and to perjury, prosecutors said. ''These guilty pleas represent the successful prosecutions of the two principal owners of perhaps the most infamous boiler room brokerage in recent history,'' said Loretta Lynch, U.S. Attorney in Brooklyn, New York. Belfort and Porush face a maximum of 20 years in prison, plus millions in fines and restitution for the hundreds of millions of dollars Stratton investors lost, said Joel Cohen, assistant U.S. Attorney in Brooklyn, who prosecuted the case. The men have already forfeited property worth at least $16 million. No date has been set for sentencing, because Belfort and Porush may have to testify in other cases, Cohen said. The men will be sentenced by U.S. District Judge John Gleeson in Brooklyn. ''Dan (Belfort) takes a step to put all this behind him, and today is the first day of the rest of his life,'' said Charles Stillman, Porush's attorney. Belfort's attorney, Gregory O'Connell, declined to comment. Stratton, based in Lake Success, New York, was expelled from the securities industry in December 1996 for a history of sales abuses. It is being liquidated under the supervision of a court-appointed trustee. Among the crimes Belfort and Porush admitted to were manipulating shares of Dollar Time Group, a Fort Lauderdale, Florida-based discount retailer, and Acquanatural Co., a distributor of water purification equipment. Stratton stockbrokers allegedly pressured their customers to buy Dollar Time stock, at the request of Belfort and Porush, as the executives were selling their own shares in the companies. The men smuggled millions of dollars to foreign companies they controlled to illegally buy the stocks and then resold them in violation of a Securities and Exchange Commission exemption for foreign sales of U.S. securities. Dollar Time filed for Chapter 11 bankruptcy protection in 1995. Its ex-chief financial officer, Gary Kaminsky, was indicted for money laundering in 1994. Other company IPOs Belfort and Porush are accused of manipulating include: Steven Madden Ltd., Select Media Communications Inc., The Solomon-Page Group Ltd. and United Leisure Corp., Ventura Entertainment Corp., Nova Capital Inc., IPS Healthcare Inc., DVI Financial Corp., Ventura Motion Picture Corp., Ropak Laboratories, Licon International Inc., Healthcare Imaging Services Inc., Repossession Auction Inc., Nutrition Management Services Co., SMT Health Services Inc., Judicate Inc., PDK Labs, Out-Takes Inc., Computer Marketplace, Master Galzier's Karate International Inc., Octagon Inc., M.H. Meyerson & Co., IDM Environmental Corp., Childrobics Inc., Select Media Communications Inc., Dualstar Technologies Corp., Czech Industries Inc., CSI Computer Specialists Inc., MVSI Inc., Hemisphere BioPharma Inc., Paramount Financial Corp., International Dispensing Corp., e-Net Inc. and n-Vision Inc., Belfort separately admitted to two counts for his role in manipulating the IPOs of Big City Bagels Inc. and Pallett Management Systems Inc. after he left Stratton Oakmont. Sep/23/1999 13:16 ---------------------------------------------------http://web.archive.org/web/20000613224158/http://www.thetrut... - History of Officers:Harris Freedman and Sharon Will, who according to AMPD's SEC filing dated Nov 28, 1998 Exhibit 6 have both been VP's at AMPD since July 1996, have also been associated with three companies named October 2, 1998 by the New York State Attorney General in a stock -- manipulation indictment.Sharon Will has been Amplidyne's VP of IR since July 1996. Harris Freedman, has been the VP of Strategic Alliances since July 1996. But, Sharon and Harris have been quite busy, because they also have been working together at Hemispherx Biopharma (HEB) since 1994.In addition, Mr. Freedman and Ms. Wills have both been accused by Securities Fraud Investigator Manuel Asensio of promoting Hemispherx Biopharma, Inc. (AMEX: HEB). Mr. Asensio claims HEB promotes a fraudulent cure for Chronic Fatigue Syndrom (CFS).Here are the BIOS of Freedman and Will from the Amplidyne web site: Exhibit 6Harris Freedman has served as Vice President of Strategic Alliances of the Company since July 1996. Since August 1994 he has been Vice President of Hemispherx Biopharma, Inc., a publicly traded company listed on Nasdaq. He is the Secretary of SMACS Holdings Corp. a private company which provides strategic-alliance services to emerging technology companies in the private and public markets. His business experience has encompassed developing significant business contacts and acting as an officer of several companies in the pharmaceutical, health care and entertainment fields. Mr. Freedman was Vice President of U.S. Alcohol Testing of America, Inc. from August 1990
to February 1991. Additionally, he was Vice President - East Coast Marketing for MusicSource U.S.A., Inc. from October 1992 to January 1994. Mr. Freedman attended New York University from 1951 to 1954.Sharon Will has been Vice President of Corporate Communications and Investor Relations of the Company since July 1996. Since November 1994 she has been Vice President of Hemispherx Biopharma, Inc., a publicly traded company listed on Nasdaq. She was a registered sales representative and Senior Vice President for Institutional Sales at
Westfield Financial Corporation from September 1994 to October 1994. She was a registered sales representative with Marsh Block Corporation from July 1994 to September 1994. From October 1993 to July 1994 she served as a registered sales representative at Seaboard Securities Corp. From October 1991 to present, Ms. Will has been President of Worldwide Marketing Inc. a manufacturer's representative of various companies selling to the retail trade markets. Ms. Will was the National Sales Manager of Innovo, Inc., a domestic manufacturer of textiles, from October 1989 to November 1991. She attended Baylor College as an undergraduate for two year with primary focus on chemistry.In addition, Mr. Freedman and Ms.Wills have both been accused by Securities Fraud Investigator Manuel Asensio of promoting Hemispherx Biopharma, Inc. (AMEX: HEB). Mr. Asensio claims HEB promotes afraudulent cure for Chronic Fatigue Syndrom (CFS). Read about it here:
Exhibit 8May 21, 1999Hemispherx officers tied to other manipulated stocks.Harris Freedman and Sharon Will, who have been vice presidents of Hemispherx Biopharma Inc. (AMEX: HEB) since 1994, and a former Hemispherx board member, Stephen J. Drescher, have been associated with three of the companies named in a press release announcing the October 2, 1998 New York State Attorney General stock-manipulation indictment. Hemispherx was one of the named companies. Mr. Freedman, Ms. Will, and Mr. Drescher, along with Hemispherx's underwriters, are as a group connected to a number of other companies associated with fraudulent activities.Mr. Freedman and Ms. Will, either directly or indirectly, controlled substantial amounts of Netsmart Technologies, Inc. (NASDAQ: NTST) and Big City Bagels, Inc. (NASDAQ: VILN) stock before their respective 1996 initial public offerings. Monroe Parker Securities, Inc., one of the indictment's named defendants, underwrote the Big City Bagels and Netsmart IPOs. Mr. Drescher was a board member of Big City Bagels and was Monroe Parker's Director of Corporate Finance at the time it took those companies public. Both Netsmart and Big City Bagels were named in the stock-manipulation release.Mr. Freedman and Mr. Drescher have also both been corporate officers and shareholders of MusicSource USA Inc. (OTC: MUSS), which was delisted by NASDAQ in April 1995 and last traded on April 30, 1999 at 4 cents. Mr. Drescher served as MusicSource's president from February 1994 until November 1996. Mr. Freedman had been a vice president at MusicSource from October 1992 until January 1994. According to a September 1996 report in the Palm Beach Post, five stockbrokers pleaded guilty to accepting bribes from a stock promoter in exchange for persuading clients to buy stocks in several companies, including MusicSource. In September 1998, according to a report in the Orange County Register, the U.S. Attorney's Office charged ten additional brokers with accepting bribes to sell stocks including
MusicSource. |
